Have a Karnofsky performance status greater than or equal to 50 for patients aged 16 years or older and a Lansky performance status greater than or equal to 50 for patients less than 16 years old
Age greater than or equal to (>/=) 18 years
Age greater than or equal to (>/=) 18 years
Age greater than or equal to 18 years
Age above or equal to 18 years
Patients must have a Karnofsky performance status of greater than or equal to 50 for patients older than 16 years of age or Lansky performance status of greater than or equal to 50 for patients less than or equal to 16 years of age.
Performance status: Karnofsky score greater than or equal to 70%. Additional Patient Inclusion Criteria for Conditioning:
Karnofsky equal or greater than 70
Be greater than or equal to (>=) 16 years of age at the time of consent.
Karnofsky performance status greater than or equal to 70%
Participants less than or equal to 16 years of age: Lansky greater than or equal to 50
Participants greater than 16 years of age: Karnofsky greater than or equal to 50 or Eastern Cooperative Oncology Group (ECOG) less than 3.
Lansky play score greater than or equal to 50% or Karnofsky Performance Status score greater than or equal to 50%. Use Karnofsky for participants greater than or equal to 16 years of age and Lansky for participants less than 16 years of age.
The ECOG performance status must be greater than or equal to 2.
Karnofsky greater than or equal to 80%
Patients with untreated AML must meet at least one of the following conditions:\r\n* Age greater than or equal to 75 years;\r\n* Age greater or equal to 60 and less than 75 years with at least one of the following poor prognostic factors:\r\n** Secondary AML, as determined by known and documented exposure to chemotherapy or radiation therapy\r\n** Antecedent history of MDS or myeloproliferative disorder according to WHO criteria for at least 3 months prior to trial entry;\r\n** Unfavorable cytogenetic abnormalities including chromosome 5 and 7 as well as complex;\r\n** ECOG performance status 2
Karnofsky performance status greater than or equal to 70%
Have a Karnofsky performance status greater than or equal to 50 for patients aged 16 years or older and a Lansky performance status greater than or equal to 50 for patients less than 16 years old
Performance status Lansky for children =< 16 years equal to at least 60, or greater Karnofsky status for those > 16 years of age equal to at least 70 or greater
Performance status (Eastern Cooperative Oncology Group [ECOG]) must be less than or equal to 2 (Karnofsky greater than or equal to 50)
Karnofsky performance status greater than or equal to 60%
Age greater than or equal to 15 years
Subjects must have Eastern Cooperative Oncology Group (ECOG) Performance Status of ) to 2 for subjects greater than or equal to 75 years of age, or 0 to 3 for subjects greater than or equal to 60 to 74 years of age
Age greater than or equal to (>=)18 years
Age greater than or equal to 18 years at the time of informed consent.
Age greater than or equal to 18 years.
Man or woman greater than or equal to (>=) 18 years of age
Zubrod performance status equal to or less than 2 (Karnofsky equal to or greater than 50%)
Subject must be greater than or equal to 65 years of age in Phase 1 and 2. Subjects enrolled in Cohort C must be either:
greater than or equal to 75 years of age; OR
of 0 to 2 for subjects greater than equal to 75 years of age
of 0 to 3 for subjects greater than equal to 60 to 74 years of age, if 0 - 1 another co-morbidity is required to make subject eligible.
Karnofsky Performance Status greater than or equal to 70%
Adult participants greater than or equal to 18 years of age
Subject must be greater than or equal to 18 years of age.
Age greater than or equal to 18 years, either sex.
Karnofsky performance status greater or equal to 70%
DONOR: Children greater than or equal to 12 years of age who have inadequate peripheral vein access to safely undergo apheresis
Patients must have a Karnofsky performance status equal or greater than 60.
Age greater than 55 years and less than or equal to 80 years (nonmyeloablative regimen 2)
Age greater than or equal to 18 years
Must be greater or equal to 20 years of age
International Prognostic Index (IPI) score greater than or equal to 3 for patients greater than 60 years of age or age-adjusted IPI (aaIPI) score of 2 or 3 for patients less than or equal to 60 years of age
Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 2 (Karnofsky greater than or equal to 60%)
Greater than or equal to 75 years of age
Ambulatory patients greater than or equal to (?) 30 years of age
Participants less than or equal to 16 years of age must have performance status of Lansky greater than or equal to 50% and participants greater than 16 years of age must have performance status of Karnofsky greater than 50%.
Age greater than or equal to 18 years.
Adult participants, greater than or equal to (>/=) 18 years of age
Karnofsky performance status greater than or equal to 80%
At US sites, patients greater than or equal to 12 years of age may be enrolled. At non-US sites, patients must be greater than or equal to 18 years of age.
Karnofsky performance status equal or greater than 50%
The minimum age from greater than 65, to greater than 55
The minimum age from greater than 55, to greater than 18
Australian Karnofsky performance status greater than or equal to 70 as reported by the patient
Individuals greater than or equal to 18 years of age
greater than or equal to 18 years of age
Age greater than or equal to 18 years, and
ECOG performance status greater than or equal to 2